| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3973867 | Revista de Senología y Patología Mamaria | 2013 | 7 Pages |
Abstract
Hypofractionated boost seems to be well tolerated. Acute and chronic toxicities are mild. The cumulative dose does not seem to increase the incidence of fibrosis at the boost area compared with the whole breast.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Javier Sanz, Nuria RodrÃguez, Jackson Lio, Palmira Foro, Anna Reig, Enric Fernández-Velilla, Joan Lozano, Ismael Membrive, Oscar Pera, Jaume Quera, Manuel Algara,